Ris-Rez Clinical Trials

3 actively recruiting trials across 2 locations

No change since August 2026

Pipeline

Phase 1: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

GlaxoSmithKline3

Indications

Cancer3
Neoplasms, Lung1
Neoplasms1
Sarcoma1
Lung Cancer1

Other1 trial

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

Phase 1/2

Los Angeles, California1 trial

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

GSK Investigational Site

Phase 3

Stanford, California1 trial

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

GSK Investigational Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.